{
    "nctId": "NCT00916877",
    "briefTitle": "Prophylactic Cranial Irradiation in Patients With HER-2-Positive Metastatic Breast Cancer",
    "officialTitle": "Prophylactic Cranial Irradiation in Patients With HER-2-Positive Metastatic Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 110,
    "primaryOutcomeMeasure": "To evaluate the safety of PCI, specifically with respect to neurocognitive function in patients with HER-2-positive metastatic breast cancer.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female with HER2-positive disease\n* 18 years of age or older\n* ECOG greater or equal to 2\n* Life expectancy greater or equal to 6 months\n* Able to complete self administered quality of life evaluations and neurocognitive testing\n* Willing and able to comply with study instructions and commit to all clinic visits for the duration of the study\n* Women of child-bearing potential must have a negative serum pregnancy test at screening and a negative urine pregnancy test at the baseline visit and must use highly effective birth control during study\n* Signed informed consent form\n\nExclusion Criteria:\n\n* Current malignancy in the brain, as determined by screening MRI/CT done no more then 6 weeks prior to study treatment with PCI\n* Chemo or radiation planned during the period when patients will receive study treatment with PCI\n* Prior radiotherapy of the brain\n* Prior stroke or brain hemorrhage in the 6 months prior to screening\n* History of neurological/psychiatric disorders, including psychotic disorders or demential, or any other reason, which may affect neurocognitive assessment\n* Inadequate renal function\n* Other known previous or concomitant serious illness or medical condition that may interfere with participation in the study",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}